Literature DB >> 20923261

Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?

Elisabeth A Innes.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20923261     DOI: 10.1586/erv.10.113

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  20 in total

1.  Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.

Authors:  Imran Rashid; Nathalie Moiré; Bruno Héraut; Isabelle Dimier-Poisson; Marie-Noëlle Mévélec
Journal:  Med Microbiol Immunol       Date:  2016-10-18       Impact factor: 3.402

2.  Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.

Authors:  Nian-Zhang Zhang; Si-Yang Huang; Ying Xu; Jia Chen; Jin-Lei Wang; Wei-Peng Tian; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

3.  Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.

Authors:  Mohammad Taghi Rahimi; Shahabeddin Sarvi; Mahdi Sharif; Saeid Abediankenari; Ehsan Ahmadpour; Reza Valadan; Mahdi Fasihi- Ramandie; Seyed-Abdollah Hosseini; Ahmad Daryani
Journal:  Parasitol Res       Date:  2016-12-02       Impact factor: 2.289

4.  Repurposing auranofin for treatment of Experimental Cerebral Toxoplasmosis.

Authors:  Iman Fathy Abou-El-Naga; Nermine Mogahed Fawzy Hussein Mogahed
Journal:  Acta Parasitol       Date:  2021-02-08       Impact factor: 1.440

5.  A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.

Authors:  Hayam Mohamed Ezz Eldin; Hanan Hussein Kamel; Abeer Fathy Badawy; Lobna Sadek Shash
Journal:  J Parasit Dis       Date:  2013-11-20

6.  Effect of HIV aspartyl protease inhibitors on experimental infection with a cystogenic Me49 strain of Toxoplasma gondii.

Authors:  Iman Fathy Abou-El-Naga; Maha Mohamed Gomaa; Samar Nabil ElAchy
Journal:  Pathog Glob Health       Date:  2021-08-22       Impact factor: 3.735

7.  Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3.

Authors:  Nian-Zhang Zhang; Si-Yang Huang; Dong-Hui Zhou; Jia Chen; Ying Xu; Wei-Peng Tian; Jing Lu; Xing-Quan Zhu
Journal:  BMC Infect Dis       Date:  2013-10-31       Impact factor: 3.090

8.  Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.

Authors:  Jia Chen; Zhong-Yuan Li; Si-Yang Huang; Eskild Petersen; Hui-Qun Song; Dong-Hui Zhou; Xing-Quan Zhu
Journal:  BMC Infect Dis       Date:  2014-09-06       Impact factor: 3.090

9.  Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.

Authors:  Nian-Zhang Zhang; Ying Xu; Meng Wang; Jia Chen; Si-Yang Huang; Qi Gao; Xing-Quan Zhu
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

10.  Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice.

Authors:  Xiao T Ching; Mun Y Fong; Yee L Lau
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.